Chin Mark
SEC CIK 1734389 · EDGAR
BoughtSold
Most active insiders at PYXS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dupont Jakob | Dir | — | $107.1K |
| 2 | Wadhane Jitendra | Prin Fin, Acct Off | — | — |
Chin Mark made no open-market trades at PYXS in the last 12 months.
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-04-25 | 2022-04-21 | PYXS | Pyxis Oncology, Inc. | Chin Mark | Former Dir | S - Sale | $3.05 | -1.75M | 0 | -100% | -$5.32M |
| 2022-04-04 | 2022-03-31 | PYXS | Pyxis Oncology, Inc. | Chin Mark | Dir | A - Grant | $0.00 | +66.8K | 66.8K | New | $0 | |
| DI | 2021-10-15 | 2021-10-13 | PYXS | Pyxis Oncology, Inc. | Chin Mark | Dir | P - Purchase | $16.00 | +312.5K | 1.75M | +22% | +$5.00M |
| DI | 2021-10-15 | 2021-10-13 | PYXS | Pyxis Oncology, Inc. | Chin Mark | Dir | C - Cnv Deriv | — | +1.43M | 1.43M | New | — |
| I | 2021-07-28 | 2021-07-16 | ELVN | Enliven Therapeutics, Inc. | Chin Mark | Dir | P - Purchase | $6.00 | +1.33M | 2.34M | +132% | +$8.00M |
Purchase Sale Sale after option exercise All abbreviations